Zogenix Inc (USD)
ZGNX
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range22.67 | 24.50
52-Wk Range |
Last Close23.10
Mkt Cap (m)1,274.57
Dividend yield-
ISINUS98978L2043
Volume735,028
Exchange VenueNAS

Company Profile

Zogenix Inc is a pharmaceutical company engaged in commercializing and developing therapies that address clinical needs for people living with pain-related and CNS disorders that needs treatment alternatives to help return to normal daily functioning.

Key Information
Price/Earning-
Price/Book5.20
Price/Sales272.78
P/CF-
Rev Growth (3 year avg)-49.81
EPS Growth (3 year avg)-
Operating Margin % -11628.87
Net Margin %-11499.53
Return on Equity-109.27
Debt/Equity0.05

Documents

Prospectus
en 04/03/2020
Annual Report
en 31/12/2019

Financials

Income Statement
USD201420152016201720182019
Revenue (m)41272910-4
Operating Income (m)-99-50-62-94-140-424
Net Income (m)926-70-127-124-420
Basic EPS0.481.22-2.81-4.65-3.27-9.74
Avg. Diluted Shares Outstanding (m)182125273843
Balance Sheet
USD201420152016201720182019
Current Assets (m)78185120305533287
Non Current Assets (m)125121112113116127
Total Assets (m)203306232418648414
Current Liabilities (m)443020215895
Total Liabilities (m)------
Total Equity (m)55183121302523245
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)-81-65-73-76-112-112
Capital Expenditure (m)-1-9
Figures are quoted in USD unless stated otherwise
-
No change
$
23.10
Last Price